Total Funding
16
Total FundingSeries A raised
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
238590
TARGET PharmaSolutions based on the success of HCV-TARGET,
Neal Bibeau: CEO
Joy Peter: Co-FounderPast Role: Emory University, Research Nurse
About the Company
TARGET PharmaSolutions was formed in February 2015, based on the success of HCV-TARGET, a case study of the model in Hepatitis C. Formed in 2011 by Dr. Michael Fried (University of North Carolina) and Dr. David Nelson (University of Florida), HCV-TARGET has $27 M committed to date, 6000 patients, and 50 clinical sites. The FDA has entered into a
Memo of Understanding with HCV-TARGET and is an active participant on the advisory committee directing the clinical analysis. Through the utilization of this data, one sponsor has expanded their label and others have mitigated costly Phase IV commitments.
Women Founded
